Related Experiment Video
Updated: May 13, 2026
08:51
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
A pH-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector for gene delivery
Huaping Chen1, Xueping Liu1, Yin Dou2
1Institute of Respiratory Diseases, Xinqiao Hospital of Third Military Medical University, Chongqing 400037, China.
Biomaterials
|March 14, 2013
Summary
Researchers developed a novel pH-responsive nanovector for delivering oligonucleotide therapeutics. This new system demonstrated superior efficacy and reduced toxicity compared to existing methods, offering a promising advancement for gene therapy applications.
Area of Science:
- Biotechnology
- Nanomedicine
- Molecular Biology
Background:
- Oligonucleotide therapeutics face significant delivery challenges hindering clinical translation.
- Nonviral vectors utilizing acid-labile materials are promising for intracellular payload delivery.
Purpose of the Study:
- To design and evaluate a novel pH-responsive nanovector for enhanced oligonucleotide delivery.
- To assess the efficacy and safety of the nanovector in cancer cells.
Main Methods:
- A hybrid nanovector was created by combining pH-responsive cyclodextrin and low molecular weight polyethylenimine (PEI).
- Antisense oligonucleotide (ASON) Bcl-xl was loaded into the nanovector using a nanoemulsion technique.
- Transfection efficiency, gene silencing, and apoptosis were evaluated in human lung adenocarcinoma cells.
Main Results:
- The nanovector achieved high loading efficiency for ASON Bcl-xl.
- Efficient cellular uptake and gene silencing of Bcl-xl were observed in a time- and dose-dependent manner.
- The nanovector exhibited superior efficacy and lower cytotoxicity compared to PLGA, branched PEI, and Lipofectamine 2000.
Conclusions:
- The developed pH-responsive hybrid nanosystem represents a safe and effective nonviral vector for oligonucleotide delivery.
- This nanovector holds potential for broad applications in gene therapy, particularly for cancer treatment.
